132 related articles for article (PubMed ID: 28133018)
41. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
Bijelic L; Yan TD; Sugarbaker PH
Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
[TBL] [Abstract][Full Text] [Related]
42. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes.
Sahajpal A; Vollmer CM; Dixon E; Chan EK; Wei A; Cattral MS; Taylor BR; Grant DR; Greig PD; Gallinger S
J Surg Oncol; 2007 Jan; 95(1):22-7. PubMed ID: 17066435
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of postoperative oxaliplatin- or irinotecan-based chemotherapy after curative resection of synchronous liver metastases from colorectal cancer.
Hsu HC; Chou WC; Shen WC; Wu CE; Chen JS; Liau CT; Lin YC; Yang TS
Anticancer Res; 2013 Aug; 33(8):3317-25. PubMed ID: 23898098
[TBL] [Abstract][Full Text] [Related]
44. Risk factors for the requirement of surgical or endoscopic interventions during chemotherapy in patients with uncomplicated colorectal cancer and unresectable synchronous metastases.
Yun JA; Park Y; Huh JW; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
J Surg Oncol; 2014 Dec; 110(7):839-44. PubMed ID: 25043872
[TBL] [Abstract][Full Text] [Related]
45. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Königsrainer I; Beckert S; Brücher B; Zieker D; Königsrainer A
Dtsch Med Wochenschr; 2011 Sep; 136(36):1811-4. PubMed ID: 21882140
[TBL] [Abstract][Full Text] [Related]
46. Peritoneal cytology in colorectal cancer.
Banerjee A; Seymour M
Dis Colon Rectum; 1999 May; 42(5):686-7. PubMed ID: 10344697
[No Abstract] [Full Text] [Related]
47. Prognostic factors for peritoneal carcinomatosis originating from colorectal cancer: an analysis of 921 patients from a multi-institutional database.
Ozawa H; Kotake K; Kobayashi H; Kobayashi H; Sugihara K
Surg Today; 2014 Sep; 44(9):1643-50. PubMed ID: 24077999
[TBL] [Abstract][Full Text] [Related]
48. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients.
Baratti D; Kusamura S; Iusco D; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
Dis Colon Rectum; 2014 Jul; 57(7):858-68. PubMed ID: 24901687
[TBL] [Abstract][Full Text] [Related]
49. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center.
Carpizo DR; Are C; Jarnagin W; Dematteo R; Fong Y; Gönen M; Blumgart L; D'Angelica M
Ann Surg Oncol; 2009 Aug; 16(8):2138-46. PubMed ID: 19495884
[TBL] [Abstract][Full Text] [Related]
50. Prediction of Early Recurrence After Curative Resection of Colorectal Liver Metastasis and Subsequent S-1 Chemotherapy.
Yamauchi K; Kokuryo T; Yokoyama Y; Uehara K; Yamaguchi J; Nagino M
Anticancer Res; 2016 May; 36(5):2175-9. PubMed ID: 27127120
[TBL] [Abstract][Full Text] [Related]
51. Factors affecting R0 resection of colorectal cancer with synchronous peritoneal metastases: a multicenter prospective observational study by the Japanese Society for Cancer of the Colon and Rectum.
Shida D; Kobayashi H; Kameyama M; Hase K; Maeda K; Suto T; Itabashi M; Funahashi K; Koyama F; Ozawa H; Noura S; Ishida H; Kanemitsu Y; Kotake K; Sugihara K
Int J Clin Oncol; 2020 Feb; 25(2):330-337. PubMed ID: 31677019
[TBL] [Abstract][Full Text] [Related]
52. Prognoses and treatment strategies for synchronous peritoneal dissemination of colorectal carcinoma.
Sato H; Toyama K; Koide Y; Ozeki S; Hatta K; Maeda K
Surg Today; 2016 Jul; 46(7):860-71. PubMed ID: 26433728
[TBL] [Abstract][Full Text] [Related]
53. The prognostic value of the primary tumor’s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy.
van der Stok EP; Grünhagen DJ; Alberda WJ; Reitsma M; Rothbarth J; Verhoef C
Dig Surg; 2015; 32(3):208-16. PubMed ID: 25896431
[TBL] [Abstract][Full Text] [Related]
54. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases.
Kawamura J; Yazawa T; Sumida K; Kida Y; Ogawa R; Tani M; Kawasoe J; Yamamoto M; Harada H; Yamamoto H; Zaima M
World J Surg Oncol; 2016 Feb; 14():56. PubMed ID: 26911142
[TBL] [Abstract][Full Text] [Related]
55. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.
Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G
Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458
[TBL] [Abstract][Full Text] [Related]
56. Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Sluiter NR; de Cuba EM; Kwakman R; Meijerink WJ; Delis-van Diemen PM; Coupé VM; Beliën JA; Meijer GA; de Hingh IH; te Velde EA
Clin Exp Metastasis; 2016 Apr; 33(4):297-307. PubMed ID: 26873137
[TBL] [Abstract][Full Text] [Related]
57. [The primary tumour resection with extended D3 lymph node dissection, metastases of synchronous metastatic colorectal cancer].
Tsar'kov PV; Kravchenko AIu; Tulina IA; Mirakian SS
Khirurgiia (Mosk); 2012; (6):28-35. PubMed ID: 22951611
[TBL] [Abstract][Full Text] [Related]
58. Treatment results of peritonectomy combined with perioperative chemotherapy for colorectal cancer-patients with peritoneal carcinomatosis.
Yonemura Y; Ishibashi H; Sako S; Kitai T; Mizumoto A; Hirano M; Ichinose M; Takao N; Matsuda N; Togawa T; Ozamto Y; Chang-Yun L; Elnemr A; Li Y; Xiao-Jun Y
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1987-91. PubMed ID: 22202261
[TBL] [Abstract][Full Text] [Related]
59. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials.
Elias D; Delperro JR; Sideris L; Benhamou E; Pocard M; Baton O; Giovannini M; Lasser P
Ann Surg Oncol; 2004 May; 11(5):518-21. PubMed ID: 15123461
[TBL] [Abstract][Full Text] [Related]
60. Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer.
Watanabe K; Kawahara H; Enomoto H; Toyama Y; Akiba T; Yanaga K
Anticancer Res; 2013 Sep; 33(9):4029-32. PubMed ID: 24023346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
